The Breathe Team
Edmonton, Alberta, T5N 3G8, Canada
NCT Number: NCT02970734
Anxiety is a common mental health problem for Canadian adolescents. Anxiety that is diagnosed as a disorder and serious enough to require treatment affects up to 10% of all adolescents by the age of 16. The median age of onset is 11 years, making these disorders some of the earliest to develop. Anxiety disorders can have serious negative effects on a young person's personal relationships, school performance, and family life. These disorders may not be discovered by adolescents, parents and health care providers. Even if anxiety disorders are discovered, adolescents may not get the right therapy. Anxious adolescents can become sick if their anxiety is not treated properly. The investigators will carry out research to test Breathe, an Internet-based treatment for adolescents with anxiety problems. Adolescents can use this treatment from home via the computer. Breathe will include information materials and personalized homework assignments to help anxious adolescents learn ways to manage anxiety. More information can be found and www.TheBreatheStudy.com
Looking for future studies?
Notify Me13 year–19 year
All sexes
Interventional
Not applicable
Edmonton, Alberta, T5N 3G8, Canada
This study is a randomized controlled trial (RCT) with two groups, an Internet-delivered cognitive behavioural therapy (CBT) experimental group (Breathe) and a resource webpage (control group; considered treatment as usual for youth waiting for services). The investigators will evaluate several methodological processes and outcomes through the following objectives:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Six web-based cognitive behavioural therapy sessions. Telephone and email support are also provided during the program.
Static webpage listing anxiety resources.
Time frame: baseline to 6 weeks post-baseline (post-intervention)
Time frame: 6 weeks post-baseline (post-intervention) to 18 weeks post-baseline (3-month follow-up)
Time frame: baseline to 6 weeks post-baseline (post-intervention), 6 weeks post-baseline (post-intervention) to 18 weeks post-baseline (3-month follow-up)
Time frame: 6 weeks post-baseline (post-intervention)
Developed by the investigators, this electronically administered, self-report instrument will assess participant satisfaction (e.g., ease of use, layout, convenience) perceived credibility and impact (e.g., helpfulness, knowledge gains, confidence in the program/website), and adherence and usage (e.g., barriers and facilitators to treatment) with an Internet-based program/webpage.
Time frame: 6 weeks post-baseline (post-intervention)
Intervention adherence will be measured by documenting the number of sessions and homework tasks completed. The investigators will also record the number of tailored sessions completed by each participant (intervention condition) and site visits (control condition). These data will be collected through the intervention's software system.
Time frame: baseline, 18 weeks post-baseline
Developed by the investigators, this self-report instrument will assess whether participants have accessed health care resources (i.e., met with a psychologist/psychiatrist/family doctor/hospital etc.) and if so, how many times.
Time frame: Through study conduct, an average of 1 year.
Time frame: Through study conduct, an average of 1 year.
University of Alberta
Other
Evaluating an Internet-based Program for Anxious Adolescents: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06942637
Adolescents, Anxiety
Bandung, West Java, Indonesia
View Trial DetailsNCT07739381
Anxiety, Anxiety Disorders
Kütahya, Turkey (Türkiye)
View Trial DetailsNCT07421063
Anxiety, Anxiety Disorders
Bolu, Turkey (Türkiye)
View Trial DetailsNCT05438446
Anxiety, Anxiety Disorders
Athens, Attica, Greece
View Trial Details